The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
How comes there was no Rns on the agm outcome, the shareholder who could not attend have no clue what was agreed
I would hope all the research, patents, and supply chain mean IF et al shall be pushing against multiple new open doors after Jan.
Good to see no share action after the AGM, perhaps next year IF should give an option to dial in....
W$
I am hoping that JuneYao Qin drink will re-launch when FF is available to them. That was a big one that was pulled due to the regulation changes in 2016. They had done all the product research and development and successful mini-launch before being pulled. Stands to reason that they will continue with it.
gixer,
Fully agreed. Once BH launch a product the whole FF scenario will change.
"sneaked"?
I don't think so. Its been there since By-Health decided to launch of a number of Fruitflow® based products.
"If By-Health is successful in obtaining a new permitted health function claim for functional health foods such
as Fruitflow that can demonstrate an anti-platelet effect, it is currently expected that this would result in some
significant orders for Fruitflow, potentially at a multiple of current total sales values."
If you don't think the jam will come why are you here?
Positive statement but the word "potential" was sneaked in. Until the jam arrives it is jam tomorrow.
The planned launch is progressing well with potential sales volumes remaining at a significant multiple of existing Fruitflow sales.
Yes, FF is obviously a big part of future plans.
By-Healths English site does seem to be delayed a day or 2 compared to B-H Chinese site.
Gixer’s find now on By health site now , sounds like Fruitflow is going to be a big part of their future plans ,all getting very interesting . http://www.by-health.com/en/aboutus/news/4604/
Hope Kievsky, and others who attended, had a good meeting. It would be interesting to know whether DSM will retain a board seat or not. Is it possible that ByHealth will be represented in future?
We'll see.
Was there standing room only? !!!!!!!!!!!!!!!!!!!! LOL.
All resolutions passed.
And of course that is for 9 months not a full year !
The way ByHealth keep heaping praise on Fruitflow's efficacy suggests that you may soon be saying you wish you'd bought more at .70
IMHO
Certainly hope you are right Sphinx , I should have bought some at 0.2p but I'd lost heart.
Probably far ahead in to profit. Not too long to become profitable.
"BY-HEALTH is actively expanding the development space of multiple categories through the combination product strategy of large single products, image products and star products."
https://www-prnasia-com.translate.goog/story/380377-1.shtml?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
After all the cash and effort By-Health have put into Fruitflow so far I have no doubt that any product launch will not be "small launch word of mouth"
As a thought.........
Where would Provexis be now if DSM had put in the same effort as B-H?
Ever , unlikely , Lifespace ‘s sales are exploding , and I would expect ff to do the same , “During the reporting period, the probiotics track performed well: "Life-Space" domestic products achieved revenue of 253 million yuan, a year-on-year increase of 53.33%; overseas business LSG operating income was 124 million Australian dollars, a year-on-year increase of 21.71%, continuing to maintain a growth trend”. That’s about £30m sales in China and £70m for the rest of the territories . £100m in just a couple of years .
it is easy to forget what a big deal getting BlueCap would be.
It is easy to forget TBH , we all expected PXS to take off post EU functional food rating status , nothing happened as no one was prepared to put in a massive amount of effort and cash to float a on every shelf product. Been over this many times. Fingers crossed the Chinese do this but don't hold your breath as they may just go with small launch word of mouth slow growth .
PR Newswire
"BY-HEALTH's revenue in the first three quarters was 6.16 billion yuan, with outstanding performance in scientific research"
During the reporting period, the company's scientific research achievements were dazzling, and authoritative articles were published in the fields of independent probiotic strain development and new mechanism research of qingluoxin (fruitflow), which attracted the attention of the industry.
In September, the latest research results of Qingluosu (fruitflow) jointly released by Tomson By-Health Nutrition and Health Research Institute and Institute of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences were published in the authoritative scientific journal "Frontiers in Nutrition". The mechanism indicates that BY-HEALTH has reached a new level in the innovative research and development of new functions.
https://www-prnasia-com.translate.goog/story/380377-1.shtml?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
By-Health website
http://www.by-health.com/news-4601
gixer ,Thank you for clearing this for me
Moon has nothing to do with provexis and hasn't for years.
Not seen anything negative reported and I don't expect any news on Thursday either.
Why indicate doom and gloom when there isn't any?
Would any body be able to tell if Mr Moon has anything to do with provexis anymore ,the reason i ak is .what is going on with sis ,this gives me the chills as provexis has been quite negative recently we need some positive news on Thursday, otherwise things are not looking good for us.
Thx Gixer
it is easy to forget what a big deal getting BlueCap would be.
I appreciate the snippets that those who make the effort to attend to AGM kindly share with us. It's not a cheap day out these days, could probably buy a few million shares at current SP for the cost of it!!
W$
Couple of articles relating to China's health food market/Industry
https://www-ifooday-cn.translate.goog/13-121572-1.html?_x_tr_sch=http&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
https://www-ifooday-cn.translate.goog/13-121561-1.html?_x_tr_sch=http&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
I totally agree with you ,we need more clarity on Bh